Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase activator, in a preclinical model of systemic lupus erythematosus (SLE).

There are multiple chapters near you. Select your preferred chapter.

We are looking forward to our national education event -- Lupus & You: Answers. Advocacy. Action. This free educational series will bring you the latest in lupus research, disease management, and ...

“My journey has been anything but ordinary. I’ve faced thyroid cancer, multiple melanomas, and migraines throughout my life. Then, 17 years ago, I was diagnosed with young onset Parkinson’s disease.